1 Slichter SJ. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group[J].N Engl J Med,1997,337(26):1861-1869. 2 Benson K,Fields K,Hiemenz J,et al. The platelet refractory bone marrow transplant patient:prophylaxis and treatment of bleeding[J].Semin Oncol,1993,20(5):102-109. 3 杨眉,罗洪,舒彬,等.1786例血小板输注的疗效分析[J].中国实验血液学杂志,2013,21(4):1038-1041. 4 桂嵘,聂新民,文贤慧,等. 临床727例次单采血小板输注效果分析[J].中国实验血液学杂志,2012,20(2):381-385. 5 Metealfe P.Platelet antigens and antibody detection[J].Vox sang,2004,87:882-886. 6 Pavenski K,Freedman J,Semple Jw.HLA alloimmunization against platelet transfusions:pathophysiology,significance,prevention and management[J].Tissue Antigens,2012,79(4):237-245. 7 Kiefel V1,K6nig C,Kroll H,et a1.Platelet alloantibodies in transfused patients[J].Transfusion,2001,41(6):766-770. 8 胡维.何巍巍,胡志坚.血小板抗体检测与患者血小板输注效果的分析[J].中国输血杂志,2011,24(5):427-428, 9 广州首次发现CD36抗体引起血小板输注无效的病例[EB/OL].http://news.sohu.com/20110719/n31379165shtml. 10 Kekomäki R,Volin L,Koistinen P,et al. Successful treatment of platelet transfusion refractoriness:the use of platelet transfusions matched for both human leucocyte antigens(HLA) and human platelet alloantigens ( HPA) in alloimmunized patients with leukaemia[J]. Eur J Haematol,1998,60(2):112-118. 11 王艳春,韦庆文,肖庆.血小板抗体筛选及血小板交叉配型对血小板输注效果的影响[J].中外医学研究,2014,12(27):25-26 . 12 韩日成,张家明,陈锦艳,等.血小板抗体检测及交叉配型在血小板输注患者中的应用[J].广东医学院学报,2012,30(1):56-58 . 13 陆紫敏,梁萍,祖亚钧,等.血小板输注疗效评估及与临床的关系[J].中华临床医师杂志(电子版),2009,3(6):1017-1021. 14 林国连,高发平,陈雅雯.血小板抗原基因的分型与配型临床疗效[J].河北医学,2005,11(9):778-780. 15 焦淑贤,杨志夏,赵林,血小板输注无效[J].中国输血杂志,2008,21(4):302-306. 16 Kekomäki R.Use of HLA and HPA matched platelels in alloimmunized patients[J].Vox sang,1998,74(suppl2):359-363. 17 宋永红,朱传福,吕红娟,等.山东骨髓库汉族人群HLA-A,B,DRB1位点基因频率调查[J].中国输血杂志,2005,18(4):327-329. 18 朱传福,王淑荣,王玫,等.山东汉族人群血小板特异性抗原基因的多态性研究[J].山东医药,2006,46(14):14-16. 19 张毅,聂向民,庄云龙,等.中国鲁南地区汉族人群HLA-A,B,DRB1高分辨等位基因多态性 分析[J].中国实验血液学杂志 2011,19(6):1482-1488. |